Back to Journals » OncoTargets and Therapy » Volume 10
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,222 | Dovepress* | 13,127+ | 2,120 | 15,247 | |
PubMed Central* | 5,095 | 1,307 | 6,402 | ||
Totals | 18,222 | 3,427 | 21,649 | ||
*Since 6 April 2017 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 0 | 4 |
View citations on PubMed and Google Scholar